Skip to main content
logo
Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS · Delayed Price · Currency is USD
31.21
-0.96 (-2.98%)
At close: Mar 3, 2026

Chugai Pharmaceutical Revenue

In the year 2025, Chugai Pharmaceutical had annual revenue of 1.26T JPY with 7.46% growth. Chugai Pharmaceutical had revenue of 343.50B in the quarter ending December 31, 2025, with 13.71% growth.

Revenue
1.26T JPY
Revenue Growth
+7.46%
P/S Ratio
12.83
Revenue / Employee
159.80M JPY
Employees
7,872
Market Cap
102.94B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.26T87.33B7.46%
Dec 31, 20241.17T59.24B5.33%
Dec 31, 20231.11T-148.58B-11.79%
Dec 31, 20221.26T260.19B26.02%
Dec 31, 2021999.76B212.81B27.04%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Glass House Brands196.17M
Vaxart148.20M
Elite Pharmaceuticals140.12M
Silence Therapeutics25.83M
OpGen9.00M
Tian'an Technology Group2.12M
Revenue Rankings

Chugai Pharmaceutical News

More News